AAM
RXDX

AR Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

AR Asset Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$5.41M Sell
2022
Q4 		$5.59M Sell
2022
Q3 		$3.01M Buy
2022
Q2 		$1.41M Buy
2022
Q1 		$1.05M Hold
2021
Q4 		$1.1M Buy